SINTX refocuses on medical devices; Q1 cash doubles to $6.5M, cash burn halved

Sintx Technologies, Inc.

Cash on hand $6.5M at March 31, 2025, up from $3.6M at year-end 2024.
Operating cash burn reduced to $1.3M in Q1 2025 from $2.7M in Q1 2024.
Raised $5.0M via private placement in Feb 2025; warrants may add $5.0M at $3.32/share.
Sold non-core subsidiary TA&T, shut down Armor subsidiary; negotiating lease reductions.
New Board appointments and long-term employment agreements with CEO and CIO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.